No Appeal of LDT/FDA Lawsuit

No Appeal of LDT/FDA Lawsuit

The FDA had until May 30 to appeal U.S. District Court Judge Sean D. Jordan's decision to vacate the agency's Final Rule seeking to regulate laboratory developed tests (LDTs). The federal government declined to appeal the judge's decision meaning the Texas District Court's decision to vacate, in its entirety, the FDA's attempt to regulate LDTs as medical devices stands.

Read ACLA’s full lawsuit.

Read the Final Judgment.

 

TELCOR POC Device Connectivity Updates - Q4 2025

TELCOR POC Device Connectivity Updates - Q4 2025

Lincoln, NE – February 17, 2026

Read More
TELCOR Inc Earns Great Place to Work® Certification for Third Consecutive Year

TELCOR Inc Earns Great Place to Work® Certification for Third Consecutive Year

Company Recognized for Ongoing Commitment to Culture, Performance, and Innovation Lincoln, Nebraska – February 16,2026 – TELCOR Inc is proud to...

Read More
Consolidated Appropriations Act Signed Into Law, Enacts One-Year Delay of CLFS Cuts

Consolidated Appropriations Act Signed Into Law, Enacts One-Year Delay of CLFS Cuts

President Donald Trump signed the Consolidated Appropriations Act of 2026 (H.R.7148) into law on Feb. 3, delaying Medicare Clinical Laboratory Fee...

Read More